Bartlett & Co’s Immunogen Inc IMGN Stock Holding History

Bartlett & Co’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-97	Closed	–	–	936
2019 Q2	$0	Buy	+97	New	+$229	﹤0.01%	807
2016 Q1	–	Sell	-129	Closed	-$2K	–	744
2015 Q4	$2K	Hold	129	–	–	﹤0.01%	719
2015 Q3	$1K	Hold	129	–	–	﹤0.01%	737
2015 Q2	$2K	Buy	+129	New	+$1.42K	﹤0.01%	711

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bartlett & Co's IMGN Position: Q3 2019 in Review

Bartlett & Co sold out of Immunogen Inc (IMGN) in Q3 2019, closing a stake of 97 shares.

Bartlett & Co first reported a position in IMGN in Q2 2015 and held it in 4 quarters. The position peaked at $2K in Q4 2015. 189 funds tracked by Wall St. Rank hold IMGN as of Q3 2019.

Bartlett & Co reported no remaining Immunogen Inc position as of Q3 2019 after selling out during the quarter.
Bartlett & Co sold 97 Immunogen Inc shares in Q3 2019.
Bartlett & Co first reported a position in Immunogen Inc in Q2 2015 and held it in 4 quarters.
Bartlett & Co's Immunogen Inc position peaked at $2K in Q4 2015.
189 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2019.

Based on Bartlett & Co's 13F filing for Q3 2019, filed 4 Nov 2019.